Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-24-016087

Options or other derivatives

  • Director acquired 13,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patni Rajiv Director 2024-06-05 Grant or award · Employee Stock Option (right to buy) +13,500 13,500 D
Loading xslF345X05/form4-06082024_120623.xml…